The Food and Drug Administration (FDA) recently approved several agents for use in pediatric patients, including a new cervical cancer vaccine and a seasonal influenza vaccine.
The Food and Drug Administration (FDA) recently approved several agents for use in pediatric patients, including a new cervical cancer vaccine and a seasonal influenza vaccine. The agency also approved a new indication for the vaccine Gardasil; the agent can now be used for the prevention of genital warts caused by human papillomavirus (HPV) in boys and men aged 9 to 26 years.
CDC recommends nirsevimab be prioritized for highest-risk infants amid limited availability
October 26th 2023The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Navigating a complex case of pediatric COVID-19 with immunomodulatory therapies
October 21st 2023Eculizumab and anakinra should be considered in critically ill patients with severe infections that require immunomodulating therapies for life-threatening dysregulation, according to a poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition.